Investors purchased shares of St. Jude Medical Inc. (NYSE:STJ) on weakness during trading hours on Monday. $65.13 million flowed into the stock on the tick-up and $20.82 million flowed out of the stock on the tick-down, for a money net flow of $44.31 million into the stock. Of all companies tracked, St. Jude Medical had the 3rd highest net in-flow for the day. St. Jude Medical traded down ($0.10) for the day and closed at $82.88

Several equities analysts have weighed in on the stock. JPMorgan Chase & Co. reiterated a “hold” rating on shares of St. Jude Medical in a report on Sunday, July 17th. Canaccord Genuity reiterated a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Wells Fargo & Co. reiterated a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Credit Suisse Group AG lowered shares of St. Jude Medical from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $67.00 to $81.00 in a report on Tuesday, May 3rd. Finally, Wedbush lowered shares of St. Jude Medical from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $70.00 to $84.00 in a report on Friday, July 15th. Twenty-two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $75.93.

The firm has a market capitalization of $23.61 billion and a PE ratio of 36.03. The firm has a 50 day moving average price of $82.11 and a 200 day moving average price of $69.30.

St. Jude Medical (NYSE:STJ) last announced its earnings results on Wednesday, July 20th. The medical technology company reported $1.06 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.06. During the same period in the prior year, the business posted $1.07 EPS. The firm earned $1.56 billion during the quarter, compared to analyst estimates of $1.55 billion. The firm’s quarterly revenue was up 10.8% compared to the same quarter last year. On average, equities analysts forecast that St. Jude Medical Inc. will post $4.06 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Wednesday, September 28th.

Several hedge funds and institutional investors recently bought and sold shares of STJ. Advisors Asset Management Inc. raised its position in St. Jude Medical by 32.6% in the fourth quarter. Advisors Asset Management Inc. now owns 20,002 shares of the medical technology company’s stock valued at $1,236,000 after buying an additional 4,916 shares during the period. I.G. Investment Management LTD. raised its position in St. Jude Medical by 29.7% in the fourth quarter. I.G. Investment Management LTD. now owns 228,600 shares of the medical technology company’s stock valued at $14,121,000 after buying an additional 52,300 shares during the period. Dorsey & Whitney Trust CO LLC raised its position in St. Jude Medical by 6.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 54,103 shares of the medical technology company’s stock valued at $3,343,000 after buying an additional 3,484 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in St. Jude Medical by 32.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 823,890 shares of the medical technology company’s stock valued at $50,894,000 after buying an additional 199,858 shares during the period.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.